š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2004-10
Trial ID
NCT00650377
Treatments Being Tested
The objective of this study is to compare the relative bioavailability of f...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2002-06
Trial ID
NCT00835666
Treatments Being Tested
Background: * Central serous chorioretinopathy (CSC) is a disease that cau...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-04
Trial ID
NCT01585441
Treatments Being Tested
The objective of this study was to evaluate the relative bioavailability of...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2006-11
Trial ID
NCT01264302
Treatments Being Tested
The purpose of this study is to compare the rate and extent of absorption o...
Status
Completed
Location
SFBC Anapharm
Start Date
2004-11
Trial ID
NCT00871247
Treatments Being Tested
This study is designed to compare safety and efficacy of monotherapy finast...
Status
Terminated
Location
Multiple Locations
Start Date
2013-08-01
Trial ID
NCT01534351
Treatments Being Tested
The objective of this study was to evaluate the relative bioavailability of...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2006-11
Trial ID
NCT01264289
Treatments Being Tested
The objective of this study is to compare the relative bioavailability of f...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2002-06
Trial ID
NCT00835796
Treatments Being Tested
The purpose of this study to compare the rate and extent of absorption of A...
Status
Completed
Location
SFBC Anapharm
Start Date
2004-11
Trial ID
NCT00870480
Treatments Being Tested